Biosimilars

The AJMC^® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

Cost savings | Image credit: joyfotoliakid - stock.adobe.com

Report Highlights Biosimilars Savings, but High Out-of-Pocket Costs for Patients

By Julia Bonavitacola

September 27th 2024

Out-of-pocket costs for biosimilars and generics are still high for patients despite these drugs leading to estimated savings of $445 billion in 2023.

Rows of identical clear vials | Image credit: nordroden - stock.adobe.com

Drug Survival of Biosimilars, Originator TNF Inhibitors Similar

By Laura Joszt, MA

September 4th 2024

White piggy bank next to a stethoscope with health icons above it | Image credit: Kiattisak - stock.adobe.com

Biosimilar Updates: Celltrion, Costco Partnership; Amgen Sues Samsung Bioepis; Denosumab Results

By Skylar Jeremias

August 25th 2024

Interest rates control inflation | Image Credit: Thongdee - stock.adobe.com

Biosimilar Uptake Lags in US Despite Potential Cost Savings

By Cameron Santoro

August 16th 2024

eye and tech | Image credit: eevl - stock.adobe.com

FDA Approves Biosimilar Enzeevu for Eye Conditions

By Skylar Jeremias

August 13th 2024

Continuing Medical Education

September 28th 2024

Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way

0.5 Credits / General Pharmacy

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions